Published in J Can Dent Assoc on April 01, 1997
Latex allergies. J Can Dent Assoc (1997) 1.39
Contact allergic cheilitis secondary to latex gloves: a case report. J Oral Maxillofac Res (2011) 0.75
Primary myeloma cells growing in SCID-hu mice: a model for studying the biology and treatment of myeloma and its manifestations. Blood (1998) 2.60
Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med (1999) 2.39
Undergraduate education in emergency medicine. Ann Emerg Med (1990) 2.36
Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proc Natl Acad Sci U S A (2001) 2.27
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med (1985) 2.25
Herpesvirus infections in the acquired immune deficiency syndrome. JAMA (1984) 2.25
Remodelling of adipose tissue during experimental omental adhesion formation. Br J Surg (2008) 2.02
The proliferative potential of myeloma plasma cells manifest in the SCID-hu host. Blood (1999) 2.02
Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fms-like gene (FLG). Proc Natl Acad Sci U S A (1989) 1.97
Challenges to implementation of the new Coroners' (Amendment) Rules 2005: experience from a tertiary paediatric pathology centre. Med Sci Law (2007) 1.92
Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood (1999) 1.89
Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine. Proc Natl Acad Sci U S A (2001) 1.63
Selecting the future doctors: the role of graduate medical programmes. Intern Med J (2005) 1.61
Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. Am J Psychiatry (1999) 1.60
Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells. Blood (1996) 1.56
Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins. Blood (2000) 1.52
Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood (1994) 1.52
Emergency medicine--no longer a casualty. Med J Aust (1989) 1.50
The use of external data sources and ratio estimation to improve estimates of hardcore drug use from the NHSDA. NIDA Res Monogr (1997) 1.49
Increased emphasis of medically necessary oral health care. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1997) 1.42
[The evidence of human immunodeficiency virus infection in the seronegative subjects of high-risk groups]. Med Clin (Barc) (1991) 1.40
High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH. Blood (2000) 1.39
Preventable death studies: an inappropriate tool for evaluating trauma systems. Aust N Z J Surg (1997) 1.39
Does care exclude cure in palliative care? J Palliat Care (1986) 1.38
Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood (1993) 1.34
Increased anterior cingulate and caudate activity in bipolar mania. Biol Psychiatry (2000) 1.33
Compliance with infection control procedures in a dental hospital clinic. Br Dent J (1992) 1.32
Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis. Neurology (2011) 1.32
Chromosome 13 homozygosity in osteosarcoma without retinoblastoma. Am J Hum Genet (1986) 1.30
Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. Blood (1999) 1.30
An immunoassay to detect human müllerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab (1990) 1.26
Mannose-binding protein B allele confers protection against tuberculous meningitis. Pediatr Res (1999) 1.26
The esterase activity in megaloblasts, leukaemic and normal haemopoietic cells. Br J Haematol (1968) 1.25
VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myeloma. Leukemia (2008) 1.25
Plasma cell myeloma--new biological insights and advances in therapy. Blood (1989) 1.25
Deficient DNA repair in human progeroid cells. Proc Natl Acad Sci U S A (1973) 1.20
Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography. J Comput Assist Tomogr (1992) 1.16
Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells. Blood (1993) 1.16
The bone marrow stromal environment is a major factor in myeloma cell resistance to dexamethasone. Exp Hematol (1998) 1.11
The LN54 radiation hybrid map of zebrafish expressed sequences. Genome Res (2001) 1.11
Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma. Cancer Res (1998) 1.10
Human fear-related motor neurocircuitry. Neuroscience (2007) 1.07
Glutamine enhances selectivity of chemotherapy through changes in glutathione metabolism. Ann Surg (1995) 1.03
Mutagen-induced diploid human lymphoblast variants containing altered hypoxanthine guanine phosphoribosyl transferase. Somatic Cell Genet (1977) 1.02
Adult inpatient alcoholics: physical exercise as a treatment intervention. J Stud Alcohol (1988) 1.02
Effects of long ultraviolet rays on human skin: photoprotective or photoaugmentative? J Invest Dermatol (1972) 1.00
Solitary fibrous tumor of the lower urogenital tract: a report of five cases involving the seminal vesicles, urinary bladder, and prostate. Hum Pathol (2000) 0.99
Dose-dependent inhibition of cold air-induced bronchoconstriction by atropine. J Appl Physiol Respir Environ Exerc Physiol (1982) 0.99
Deletion of the retinoblastoma gene in multiple myeloma. Leukemia (1994) 0.99
Establishment of cell lines of uveal melanoma. Methodology and characteristics. Invest Ophthalmol Vis Sci (1984) 0.99
Distinguishing homozygous and heterozygous cystic fibrosis fibroblasts from normal cells by differences in sodium transport. N Engl J Med (1981) 0.99
Rectal intussusception in symptomatic patients is different from that in asymptomatic volunteers. Br J Surg (2005) 0.99
Kaposi's sarcoma and disseminated tuberculosis in HIV-negative individual. Lancet (1992) 0.97
Expression of alpha(v)beta6 integrin in oral leukoplakia. Br J Cancer (2000) 0.96
Application of UMLS indexing systems to a WWW-based tool for indexing of digital images. Proc AMIA Annu Fall Symp (1997) 0.96
The molecular basis of the action of chloroquine in porphyria cutanea tarda. J Invest Dermatol (1973) 0.96
Interaction of sulfur dioxide and dry cold air in causing bronchoconstriction in asthmatic subjects. J Appl Physiol Respir Environ Exerc Physiol (1984) 0.95
In vitro radiosensitivity of human dipliod fibroblasts derived from patients with unusual clinical responses to radiation. Radiology (1976) 0.95
Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management. Cancer (2001) 0.95
Effect of fragile X status categories and FMRP deficits on cognitive profiles estimated by robust pedigree analysis. Am J Med Genet A (2003) 0.94
Treatment patterns, health-related quality of life and adherence to prophylaxis among haemophilia A patients in the United States. Haemophilia (2012) 0.94
Increased resistance of cystic fibrosis fibroblasts to ouabain toxicity. Proc Natl Acad Sci U S A (1977) 0.94
The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J Clin Endocrinol Metab (1993) 0.93
Tolerance to sulfur dioxide-induced bronchoconstriction in subjects with asthma. Environ Res (1983) 0.93
The influence of psychological stress on periodontal disease. J West Soc Periodontol Periodontal Abstr (2000) 0.92
Oral mucosal Langerhans' cells as target, effector and vector in HIV infection. J Oral Pathol Med (2000) 0.92
Murine macrophage mannose receptor promoter is regulated by the transcription factors PU.1 and SP1. Blood (1997) 0.91
Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells. Br J Haematol (2000) 0.91
Allergic contact photodermatitis to para-aminobenzoic acid. Arch Dermatol (1978) 0.88
Preparation of individual human diploid fibroblasts and study of ion transport. Am J Physiol (1985) 0.88
Ketamine and xylazine combinations for short-term immobilization of wild variable flying foxes (Pteropus hypomelanus). J Zoo Wildl Med (2008) 0.88
The drug abuse treatment gap: recent estimates. Health Care Financ Rev (1997) 0.87
An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1998) 0.87
Inherent cellular radiosensitivity of human tumors of varying clinical curability. AJR Am J Roentgenol (1976) 0.87
Characterization and radiobiologic parameters of medulloblastoma in vitro. Cancer (1977) 0.87
Orofacial pain in cancer: part I--mechanisms. J Dent Res (2007) 0.87
Age differences in understanding of disease causality: AIDS, colds, and cancer. Child Dev (1993) 0.86
Impaired glutathione peroxidase activity accounts for the age-related accumulation of hydrogen peroxide in activated human neutrophils. J Gerontol A Biol Sci Med Sci (1998) 0.86
Analysis of HGPRT- CRM+ human lymphoblast mutants. Somatic Cell Genet (1979) 0.86
Occult hepatitis B infection in blood donors. Vox Sang (2008) 0.86
Expression of an ouabain resistance gene in transfected cells. Ouabain treatment induces a K+-transport system. J Biol Chem (1985) 0.86
Inositol 1,4,5-trisphosphate stimulates phosphorylation of a 62,000-dalton protein in monkey fibroblast and bovine brain cell lysates. J Biol Chem (1984) 0.86
Local tumor recurrence or emergence of a new primary lesion? A molecular analysis. J Oral Pathol Med (1999) 0.86
Sulfur dioxide-induced bronchoconstriction in freely breathing, exercising, asthmatic subjects. Am Rev Respir Dis (1983) 0.86
The effect of prostaglandins on the multiplication and cell-to-cell spread of herpes simplex virus type 2 in vitro. Am J Obstet Gynecol (1982) 0.86
Oral lesions in HIV-positive dental patients--one more argument for tobacco smoking cessation. Oral Dis (2007) 0.86
Recombinant human mullerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo. Cancer Res (1992) 0.86
Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia. Cancer Chemother Pharmacol (1984) 0.85
In vitro cellular radiosensitivity of human malignant tumors. Eur J Cancer (1976) 0.85
A technique for developing established cell lines from human osteosarcomas. In Vitro (1976) 0.85
Oversight and monitoring of blood safety in the United States. Vox Sang (1999) 0.85
Interdependence between cytokines and cell adhesion molecules to induce interleukin-6 production by stromal cells in myeloma. Leuk Lymphoma (1998) 0.85
Current and proposed biologic markers in prostate cancer. J Cell Biochem Suppl (1992) 0.85
A high frequency of allelic loss in oral verrucous lesions may explain malignant risk. Lab Invest (2001) 0.84
Assessment by gene amplification and serological markers of transmission of HIV-1 from hemophiliacs to their sexual partners and secondarily to their children. J Acquir Immune Defic Syndr (1990) 0.84
Correlated flow cytometric analysis of H-ras p21 and nuclear DNA in multiple myeloma. Blood (1988) 0.84
Enhanced dexamethasone resistance in cystic fibrosis cells: potential use for heterozygote detection and prenatal diagnosis. Science (1978) 0.83
Effect of exercise rate and route of inhalation on sulfur-dioxide-induced bronchoconstriction in asthmatic subjects. Am Rev Respir Dis (1983) 0.83